Epilepsy Syndromes in Children - Adolescent Onset Flashcards
common epilepsies
commonly known generalized epilepsies: juvenile absence and juvenile myoclonic epilepsy, progressive myoclonus epilepsies
focal-onset: mesial temporal lobe epilepsy with hippocampal sclerosis, autosomal dominant focal epilepsy with auditory features, and autosomal dominant nocturnal frontal lobe epilepsy
juvenile absence epilepsy
absence syndrome having later onset than childhood absence epilepsy and without typical clustering
juvenile absence epilepsy - age of onset
peaks at 15 years, with range of 10 to 19 years
juvenile absence epilepsy - symptoms
more sporadic and somewhat longer
automatisms, speech arrest, and loss of awareness are frequently seen
juvenile absence epilepsy - EEG
paroxysms of generalized 3 to 4 Hz spike- or polyspike-and-wave activity
juvenile absence epilepsy - triggers
sleep deprivation, alcohol, and hyperventilation
juvenile absence epilepsy - seizure types
myoclonic and generalized tonic-clonic seizes may occur, but are less prominent than in JME
juvenile absence epilepsy - treatment
respond to ethosuximide
broader spectrum agents (valproate or lamotrigine) useful if additional seizure types occur
generally pharmacoresponsive
juvenile absence epilepsy - medications to avoid
exacerbate absence seizures
phenytoin, carbamazepine, gabapentin, pregabalin, and vigabatrin
juvenile absence epilepsy - valproate side effects
hepatopathy, pancreatitis, thrombocytopenia
risk of congenital malformations and early childhood cognitive effects if administered to women during the first trimester of pregnancy
juvenile absence epilepsy - prognosis
achieve seizure control, but a lifelong requirement of medication is expected
juvenile myoclonic epilepsy - onset
between 12 and 18 years of age
juvenile myoclonic epilepsy - clinical features
myoclonic seizures predominantly involving the upper extremities, especially upon wakening
juvenile myoclonic epilepsy - seizure types
additionally develop generalized tonic-clonic seizures and at least one third will experience absence seizures
juvenile myoclonic epilepsy - EEG
background is preserved, but features abrupt paroxysmal generalized 4 to 6 Hz spike- or polyspike-and-slow-wave activity, sometimes described as having an inverted W configuration
discharges are potentiated by sleep and, in particular, sleep deprivation
juvenile myoclonic epilepsy - triggers
sleep deprivation, arousal, alcohol use, menses, and photic stimulation
juvenile myoclonic epilepsy - ictal EEG
myoclonic seizures tend to be accompanied by rapid polyspikes in the range of 10 to 16 Hz or fast spike-and-wave activity
generalized tonic-clonic seizures may follow escalation of the myoclonic seizures or occur independently
juvenile myoclonic epilepsy - etiology
complex genetics
may be positive family history of epilepsy
implied a role for mutations of GABRA1 gene of the GABA-A receptor as well as genes encoding for voltage-gated potassium channels, chloride channels, and other genes
juvenile myoclonic epilepsy - prognosis
mixed - seizure freedom is achievable, but remission is not expected
vast majority relapse when taken off medications
juvenile myoclonic epilepsy - treatment
valproate avoid in women of child-bearing age d/t teratogenicity and polycystic ovary syndrome
- advantage for comorbidities of migraine or bipolar
- high rate of psychiatric comorbidity exists
levetiracetam or lamotrigine
juvenile myoclonic epilepsy - meds to avoid
worsened by carbamazepine, oxcarbazepine, phenytoin, gabapentin, and vigabatrin
juvenile myoclonic epilepsy - prognostic factors
presence of generalized tonic-clonic seizures or EEG worsening during or following medication withdrawal are prognostic factors for higher risk of seizure recurrence
epilepsy with generalized tonic-clonic seizures alone - age of onset
typical age of 16 years with a range of 6 and 28 years